Skip to content

Opening book details…

About this Medicine article

Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial by Nakajima, Atsushi; Seki, Mitsunori; Taniguchi, Shinya is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Nakajima, Atsushi; Seki, Mitsunori; Taniguchi, Shinya
Publisher
Springer Japan; Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 0944-1174)
Published
2017
Language
EN
ISBN
9780053501716
Field
Medicine (Health Sciences)

More by Nakajima, Atsushi; Seki, Mitsunori; Taniguchi, Shinya

Browse all works by Nakajima, Atsushi; Seki, Mitsunori; Taniguchi, Shinya